相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。HHLA2 Immune Checkpoint Is a Novel Prognostic Predictor in Hepatocellular Carcinoma
Xiaoyan Liao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)
Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma
Long Long et al.
IMMUNOTHERAPY (2022)
HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells
Hui Guo et al.
INFLAMMATION (2022)
HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
Zeng Yang et al.
BIOMED RESEARCH INTERNATIONAL (2022)
Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
Chao Xia et al.
FRONTIERS IN IMMUNOLOGY (2022)
Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
Zaoqu Liu et al.
EBIOMEDICINE (2022)
(Im)maturity in Tumor Ecosystem
Keywan Mortezaee et al.
FRONTIERS IN ONCOLOGY (2022)
Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 Possesses Prognostic Significance and Promotes Progression of Papillary Thyroid Cancer
Yongzhi Niu et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
Peter John et al.
NATURE COMMUNICATIONS (2022)
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy
Keywan Mortezaee et al.
CELLULAR ONCOLOGY (2022)
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
Patrick Terrematte et al.
CANCERS (2022)
The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
Dawei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer
Jinghan Wang et al.
EBIOMEDICINE (2022)
NPX267, A FIRST-IN-CLASS MONOCLONAL ANTIBODY TARGETING KIR3DL3, BLOCKS HHLA2-MEDIATED IMMUNOSUPPRESSION AND POTENTIATES T AND NK CELL-MEDIATED ANTITUMOR IMMUNITY
McKenna Lamb et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinoma
Yongzhi Niu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)
B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
Sadiye Amcaoglu Rieder et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer
Keywan Mortezaee
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory for Pathway to PD1
Rupal S. Bhatt et al.
CANCER IMMUNOLOGY RESEARCH (2021)
H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
Min Luo et al.
MEDICAL SCIENCE MONITOR (2021)
HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
Guocai Xu et al.
CANCER CELL INTERNATIONAL (2021)
Organ tropism in solid tumor metastasis: an updated review
Keywan Mortezaee
FUTURE ONCOLOGY (2021)
Normalization in tumor ecosystem: Opportunities and challenges
Keywan Mortezaee
CELL BIOLOGY INTERNATIONAL (2021)
Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives
Keywan Mortezaee
LIFE SCIENCES (2021)
HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization
Wenjie Sun et al.
CANCER MEDICINE (2021)
B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion
Khang Luu et al.
FRONTIERS IN IMMUNOLOGY (2021)
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
Yao Wei et al.
SCIENCE IMMUNOLOGY (2021)
Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
Min Luo et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
Li Wei et al.
HUMAN CELL (2020)
HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis
Patrick P. C. Boor et al.
BRITISH JOURNAL OF CANCER (2020)
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Qiang-Hua Zhou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma
Zhen Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas
Zeyu Liu et al.
CANCER CELL INTERNATIONAL (2020)
B7-H7 is a prognostic biomarker in epithelial ovarian cancer
Yuanyuan Fu et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target
Dongming Chen et al.
JOURNAL OF MEDICAL GENETICS (2019)
Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy
Bagher Farhood et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival
Han Yan et al.
CANCER LETTERS (2019)
HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
Chu-Yu Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
Lujun Chen et al.
CANCER CELL INTERNATIONAL (2019)
B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma
Qi Chen et al.
CANCER SCIENCE (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
CD28H expression identifies resident memory CD8+T cells with less cytotoxicity in human peripheral tissues and cancers
Yu Tian et al.
ONCOIMMUNOLOGY (2019)
Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers
Haiying Cheng et al.
CLINICAL CANCER RESEARCH (2018)
Impaired natural killer cell subset phenotypes in human obesity
Ina Baehr et al.
IMMUNOLOGIC RESEARCH (2018)
Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
Ziwen Zhu et al.
ONCOTARGETS AND THERAPY (2018)
New B7 Family Checkpoints in Human Cancers
Ling Ni et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Frank A. Schildberg et al.
IMMUNITY (2016)
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
Murali Janakiram et al.
ONCOIMMUNOLOGY (2015)
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
Murali Janakiram et al.
CLINICAL CANCER RESEARCH (2015)
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Ruihua Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)